21-31 - Heart Failure Flashcards

1
Q

bowditch phenomenon

A

icnreases in heart rate cause an increase in contractility ( saves CO - filling time issues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

frank-starling mechanism

A

increases in preload increase the contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anrep =

A

if you increase the afterload, contractility will increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

in the excited state ____- preload is needed to increase SV because of changes in contractility

A

smaller preload to get same increase in SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

main cause CHF

A

cardiac remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

high risk for developing HF

A

stage A

  • HTN
  • CAD
  • DM
  • family hx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

asymptomatic HF

A

stage B

  • previous MI
  • LV systolic dysfunction
  • asymptomatic valvular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

symptomatic HF

A

stage C

  • known structural heart disease
  • SOB and fatigue
  • reduced exercise tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

refractory end-stage HF

A

stage D

  • marked symptoms at rest despite maximal medical therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

drug at all stages of HF

A

ACEi or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

drug starting at stage B of HF

A

b- blocker

added to ACEi or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drug starting at stage C of HF

A

lots, notably Diuretics and Digoxin added to ACEi or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

symptomatic HF, african-american race

A

hydralazine and nitrates and ACEi and B blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

symptomatic HF with afib

A

digoxin
ACEi
b-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

drug that is bridge to transplantation or end of life

A

positive ionotropes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

4 practical approaches to increase intrinsic myocardial contractility

A
  1. increase cytosolic Ca2+
  2. increase myocardial cAMP
  3. agonism of B1 receptors
  4. increase B1 receptor density
17
Q

what drugs increase B1 receptor density?

A

b1 adrenergic antagonists

18
Q

example b adrenergic agonists

A

dobutamin, epinepthrin, NE, dopamine

19
Q

what drugs increase myocardial cAMP

A

phosphodiesterase inhibitors

amrinone, milrinone

20
Q

what drugs increase cytosolic Ca2+

A

cardiac glycosides

digoxin

21
Q

MOA digoxin

A

blocks Na/K ATPase to increase intracellular sodium and extracellular Ca2+

22
Q

positive ionotropic effects of digoxin

A

decrease EDV and ESV

decrease systemic and pulmonary venous pressure

decrease SANS

23
Q

digoxin has a ____ vagal effect

A

direct –> increases vagal tone

24
Q

how does digoxin affect coronary flow

A

increases it (by decrease hypertrophy)

25
adverse effect of digoxin
proarrhythmic need to watch K levels
26
pharmacokinetics of digoxin
7 days to reach steady state excreted by kidney
27
what inactivates digoxin
eubacterium lentum and cimetidine
28
early sign of difitalis intoxication
anorexia, nausea, vomiting, visual change you will see arrhythmia later monitor K values!
29
does digoxin improve mortality?
no
30
I gave the pt too much digoxin - help!
cholestyaramin or digoxin immune Fab
31
MOA phsophodiesterase 3 inhibitors
block type III phosphodiesterase activity leading to an incrrease in caMP and --> vasodiltation, positive ionotropic and lusitropic effects
32
phosphodiesterase 3 inhibitors work downstream of what drug
b agonsits
33
what are the two phosphodiesterase 3 inhibitors?
inamrinone | milrinone
34
how do inamrinone and milrinone increase CO?
- directly stimualte myocardial contractility - accelerate relaxation - balance arterial and venous dialtion to decrease filling pressure
35
indication for inamrinone and milrinone
short term circulation support in advanced CHF